21.57USD-1.01%Mkt Cap: 3.69B USDP/E: 9.74Last update: 2026-06-01
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a se…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.69B USD
Enterprise Value2.91B USD
Revenue (TTM)1.10B USD
Gross Profit982.51M USD
Net Income (TTM)391.00M USD
Revenue/Share6.470 USD
Last Price21.57 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees796
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0042251084
Valuation
P/E (Trailing)9.74
P/E (Forward)24.26
PEG50.86
EV/EBITDA31.37
EV/Revenue2.66
P/S3.39
P/B2.97
EPS (TTM)2.21
EPS (Forward)0.89
52W Range
19.6922% of range28.35
52W High28.35 USD
52W Low19.69 USD
Profitability
Gross Margin91.69%
Oper. Margin-1.72%
EBITDA Margin8.46%
Profit Margin36.49%
ROE31.86%
ROA25.00%
Growth
Revenue Growth9.70%
Earnings Growth-81.80%
Cash Flow & Leverage
Operating CF109.84M USD
CapEx (TTM)4.69M USD
FCF Margin14.07%
FCF Yield4.18%
Net Debt-800.66M USD
Net Debt/EBITDA-8.64
Balance Sheet
Debt/Equity0.04
Current Ratio3.59
Quick Ratio3.27
Book Value/Sh7.295 USD
Cash/Share4.972 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)31.65 USD
Target Range17.00 USD – 45.00 USD
# Analysts20
Ownership
Shares Out.171.24M
Float127.34M
Insiders0.33%
Institutions99.03%
Short Interest
Short Ratio6.0d
Short % Float10.58%
Short % Out.6.67%
Shares Short11.42M
Short (prev mo.)10.98M
Technical
SMA 5021.73 (-0.7%)
SMA 20023.59 (-8.6%)
Beta0.86
S&P 52W Chg27.94%
Avg Vol (30d)1.46M
Avg Vol (10d)1.48M
Technical Indicators
RSI (14)51.5
MACD-0.1631
MACD Signal-0.1997
MACD Hist.+0.0366
BB Upper22.80 USD
BB Middle21.64 USD
BB Lower20.47 USD
BB Width10.75%
ATR (14)0.6931 USD
Vol Ratio (20d)0.48x